David A. Schaer

Senior Research Scientist

Lab Phone




My clinical research is focused on the mechanisms of GITR immunotherapy and it’s role in Treg mediated immune suppression. In particular, I am studying the effects of agonist GITR antibodies in human patients. Our group has recently started a collaboration with the Ludwig Inst/4-Antibody partnership. I am now leading this effort in our group.